Target intelligence / Profile preview

T cell receptor beta variable 2 (TRBV2)

Target
TRBV2
Molecular classification
Receptor, T cell receptor (variable region), Cell surface protein
01

Overview

T cell receptor beta variable 2 (TRBV2) is a segment of the variable domain of the β chain of the T cell receptor, essential for antigen specificity and adaptive immune function[1]. TRBV2 is part of the T cell receptor (TCR) complex expressed on αβ T lymphocytes, which recognize peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. Upon antigen binding, TCRs—via their variable domains like TRBV2—initiate intracellular signaling through the CD3 complex, activating pathways such as MAPK, calcium, and NF-κB, which control T cell proliferation, differentiation, and effector functions[1]. The diversity of the TRBV segments is generated through V(D)J recombination during thymic development, enabling recognition of a vast array of antigens[1][2]. Abnormalities or specific TRBV2 usage can be associated with certain cancers, infections, or autoimmune conditions. In therapeutic contexts, T cell receptor diversity can serve as a biomarker for immune reconstitution or clonal expansion, but targeting specific TCR Vβ segments carries a risk of immune misdirection or excessive activation[1].

Other names
TCRBV22S1A2N1TTCRBV2S1V segment translation productTVB2
02

Mechanism of action

Antigen recognition for T cell activation; Triggering intracellular signaling via interaction with peptide-major histocompatibility (pMH) complexes and CD3 co-receptors

03

Biological functions

Immune responseAntigen recognitionSignal transduction
04

Disease associations

CancerInfectionAutoimmune diseaseOther immune-related diseases
05

Safety considerations

Off-target immune responses (e.g. autoimmunity if misregulated)Cytokine release syndrome in T cell therapies targeting TCR Vβ segments
06

Biomarkers

T cell receptor repertoire diversity (for immune monitoring or minimal residual disease in leukemia/lymphoma)TCR clonotype tracking in immunotherapy

Beyond the preview

Go deeper on T cell receptor beta variable 2 (TRBV2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 2 (TRBV2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call